Recall on Zantac
Our Partner Firm, Chhabra Gibbs & Herrington PLLC, wrote about the recent Zantac recall and how the FDA has decided to pull all of the Zantac product off the shelf due to NDMA and cancer from contamination: The heartburn and ulcer medication Zantac, also known as Ranitidine, which belongs to the histamine-2 blockers category, has been recalled by the FDA. The FDA has been investigating Zantac for a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications. The FDA has determined that the impurity increases over time and when stored at higher than room temperatures, that impurity exposes consumers to an unacceptable level of it....
Continue reading